The beneficial effects of the herbal medicine free and easy wanderer plus (FEWP) and fluoxetine on post-stroke depression

Journal of Alternative and Complementary Medicine

Volumn 14, Issue 7, 2008, Pages 841-846

  Li, Lian Tao ^a,b   Wang, Shu Hua ^a   Ge, Hong You ^c   Chen, Jing ^a   Yue, Shou Wei ^a   Yu, Mei ^b  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG MEDICAL COLLEGE   (China)

^c AALBORG UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; HERBACEOUS AGENT; PLACEBO;

ADULT; AGED; ARTICLE; BARTHEL INDEX; BLEEDING; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEPRESSION; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STROKE; TREATMENT RESPONSE;

ACTIVITIES OF DAILY LIVING; AGED; ANTIDEPRESSIVE AGENTS; CHINA; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; DRUGS, CHINESE HERBAL; FEMALE; FLUOXETINE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PHYTOTHERAPY; RECOVERY OF FUNCTION; RESEARCH DESIGN; STROKE; TIME FACTORS; TREATMENT OUTCOME;

EID: 52449104649     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.2008.0010     Document Type: Article

References (45)

1. Kessler RC, Soukup J, Davis RB, et al. The use of complementary and alternative therapies to treat anxiety and depression in the United States, Am J Psychiatry 2001;158:289-294.
2. Zhang ZJ. Therapeutic effects of herbal extracts and constituents in animal models of psychiatric disorders, Life Sci 2004;75:1659-1699.
3. Maciocia G. The practice of Chinese medicine: The treatment of diseases with acupuncture and Chinese herbs. Edinburgh: Churchill Livingstone, 1994:342.
4. Zhang LD, Zhang YL, Xu SH, et al. Traditional Chinese medicine typing of affective disorders and treatment, Am J Chin Med 1994;22:321-327.
5. Mantani N, Hisanaga A, Kogure T, et al. Four cases of panic disorder successfully treated with Kampo (Japanese herbal) medicines: Kami-shoyo-san and Hange-koboku-to, Psychiatry Clin Neurosci 2002;56:617-620.
6. Yamada K, Kanba S. Herbal medicine (kami-shoyo-san) in the treatment of premenstrual dysphoric disorder. J Clin Psychopharmacol 2002;22:442.
7. Chen LC, Tsao YT, Yen KY, et al. A pilot study comparing the clinical effects of Jia-Wey Shiau-Yau San, a traditional Chinese herbal prescription, and a continuous combined hormone replacement therapy in postmenopausal women with climacteric symptoms. Maturitas 2003;44:55-62.
8. Tanaka T. Effects of herbal medicines on menopausal symptoms induced by gonadotropin-releasing hormone agonist therapy. Clin Exp Obstet Gynecol 2001;28:20-23.
9. Zhang ZJ, Kang WH, Tan QR, et al. Adjunctive herbal medicine with carbamazepine for bipolar disorders: a doubleblind, randomized, placebo-controlled study. J Psychiatr Res 2007;41:360-369.
10. Robinson RG, Morris PL, Fedoroff JP. Depression and cerebrovascular disease. J Clin Psychiatry 1990;51:26-31.
11. Robinson RG. Treatment issues in poststroke depression. Depress Anxiety 1998;8:85-90.
12. Robinson RG, Price TR. Post-stroke depressive disorders: A follow-up study of 103 patients. Stroke 1982;13:635-641.
13. Wade DT, Legh-Smith J, Hewer RA. Depressed mood after stroke. A community study of its frequency. Br J Psychiatry 1987;151:200-205.
14. Parikh RM, Robinson RG, Lipsey JR, et al. The impact of post-stroke depression on recovery activities of daily living over a two year follow up. Arch Neurol 1990;47:785-789.
15. Angeleri F, Angeleri VA, Foschi N, et al. The influence of depression, social activity, and family stress on functional outcome after stroke. Stroke 1993;24:1478-1483.
16. Morris PL, Robinson RG, Andrzejewski P, et al. Association of depression with 10 year post-stroke mortality. Am J Psychiatry 1993;150:124-129.
17. Lauritzen L, Bendsen BB, Vilmar T, et al. Post-stroke depression: combined treatment with imipramine or desipramine and mianserin. A controlled clinical study. Psychopharmacology (Berl) 1994;114:119-122.
18. Lipsey JR, Robinson RG, Pearlson GD, et al. Nortriptyline treatment of post-stroke depression: a double-blind study. Lancet 1984;11:297-300.
19. Andersen G, Vestergaard K, Lauritzen L. Effective treatment of post-stroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke 1994;25:1099-1104.
20. Dam M, Tonin P, De Boni A, et al. Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy. Stroke 1996;27:1211-1214.
21. Gonzalez-Torrecillas JL, Mendlewicz J, Lobo A. Effects of early treatment of poststroke depression on neuropsychological rehabilitation. Int Psychogeriatr 1995;7:547-560.
22. Stamenkovic M, Schindler S, Kasper S. Poststroke depression and fluoxetine. Am J Psychiatry 1996;153:446-447.
23. Wiart L, Petit H, Joseph PA, et al. Fluoxetine in early post-stroke depression: A double-blind placebo-controlled study. Stroke 2000;31:1829-1832.
24. Fruehwald S, Gatterbauer E, Rehak P, et al. Early fluoxetine treatment of post-stroke depression: A three-month double-blind placebo-controlled study with an open-label long-term follow up. J Neurol 2003;250:347-351.
25. Morris PL, Raphael B, Robinson RG. Clinical depression is associated with impaired recovery from stroke. Med J Aust 1992;157:239-242.
26. Pariente J, Loubinoux I, Carel C, et al. Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke. Ann Neurol 2001;50:718-729.
27. Pharmacopoeia of the People's Republic of China. Beijing: Chemical Industry Press, 2000.
28. Bobath B. Adult Hemiplegia: Evaluation and Treatment. London: William and Heinnemann, 1978.
29. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
30. Mahoney FI, Barthel DW. Functional evaluation: Barthel Index. Md State Med J 1965;14:61-65.
31. Beaubrun G, Gray GE. A review of herbal medicines for psychiatric disorders. Psychiatr Serv 2000;51:1130-1134.
32. Wong AH, Smith M, Boon HS. Herbal remedies in psychiatric practice. Arch Gen Psychiatry 1998;55:1033-1044.
33. Zhang ZJ, Kang WH, Li Q, et al. The beneficial effects of the herbal medicine Free and Easy Wanderer Plus (FEWP) for mood disorders: double-blind, placebo-controlled studies. J Psychiatr Res 2007;41:828-836.
34. Adell A, Castro E, Celada P, et al. Strategies for producing faster acting antidepressants. Drug Discov Today 2005;8:578-585.
35. Li DQ, Li Y, Liu Y, et al. Catalpol prevents the loss of CA1 hippocampal neurons and reduces working errors in gerbils after ischemia-reperfusion injury. Toxicon 2005;46:845-851.
36. Zhang XL, Jiang B, Li ZB, et al. Catalpol ameliorates cognition deficits and attenuates oxidative damage in the brain of senescent mice induced by D-galactose. Pharmacol Biochem Behav 2007;88:64-72.
37. Tian YY, An LJ, Jiang L, et al. Catalpol protects dopaminergic neurons from LPS-induced neurotoxicity in mesencephalic neuron-glia cultures. Life Sci 2006;80:193-199.
38. Tian YY, Jiang B, An LJ, et al. Neuroprotective effect of catalpol against MPP(-)-induced oxidative stress in mesencephalic neurons. Eur J Pharmacol 2007;568:142-148.
39. Lam BY, Lo AC, Sun X, et al. Neuroprotective effects of tanshinones in transient focal cerebral ischemia in mice. Phytomedicine 2003;10:286-291.
40. Meng XF, Zou XJ, Peng B, et al. Inhibition of ethanol-induced toxicity by tanshinone IIA in PC12 cells. Acta Pharmacol Sin 2006;27:659-664.
41. Yu XY, Lin SG, Zhou ZW, et al. Tanshinone IIB, a primary active constituent from Salvia miltiorrhza, exhibits neuroprotective activity in experimentally stroked rats. Neurosci Lett 2007;417:261-265.
42. Liu CS, Chen NH, Zhang JT. Protection of PC12 cells from hydrogen peroxide-induced cytotoxicity by salvianolic acid B, a new compound isolated from Radix Salviae miltiorrhizae. Phytomedicine 2007;14:492-497.
43. Tian LL, Wang XJ, Sun YN, et al. Salvianolic acid B, an antioxidant from Salvia miltiorrhiza, prevents 6-hydroxydopamine induced apoptosis in SH-SY5Y cells. Int J Biochem Cell Biol 2008;40:409-422.
44. Luo L, Nong Wang J, Kong LD, et al. Antidepressant effects of Banxia Houpu decoction, a traditional Chinese medicinal empirical formula. J Ethnopharmacol 2000;73:277-281.
45. Davidson JR, Abraham K, Connor KM, et al. Effectiveness of chromium in atypical depression: a placebo-controlled trial. Biol Psychiatry 2003;53:261-264.